DWS
GPCR icon

Dynamic Wealth Strategies’s Structure Therapeutics GPCR Stock Holding History

Dynamic Wealth Strategies’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05K Hold
150
– – ﹤0.01% 247
2026
Q1 		$7.23K Hold
150
– – ﹤0.01% 243
2025
Q4 		$10.4K Sell
150
-400
-73% -$16.3K 0.01% 208
2025
Q3 		$15.4K Hold
550
– – 0.01% 185
2025
Q2 		$11.4K Buy
+550
New +$12.1K 0.01% 190

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dynamic Wealth Strategies's GPCR Position: Q2 2026 in Review

Dynamic Wealth Strategies held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 150 shares worth $8.05K. The position accounts for ﹤0.01% of the portfolio, ranked #247.

Dynamic Wealth Strategies first reported a position in GPCR in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.4K in Q3 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Dynamic Wealth Strategies held 150 shares of Structure Therapeutics worth $8.05K as of Q2 2026.
  • Dynamic Wealth Strategies left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Dynamic Wealth Strategies's portfolio in Q2 2026, its #247 holding.
  • Dynamic Wealth Strategies first reported a position in Structure Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Dynamic Wealth Strategies's Structure Therapeutics position peaked at $15.4K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2026, filed 23 Jul 2026.